News
Zeotap launches Predictive Audiences to empower marketers with machine learning
Zeotap the leading Customer Data Platform, has today announced the launch of Predictive Audiences as part of its award-winning Customer Intelligence Platform (CIP). Designed to help marketing users increase the impact of their campaigns, it enables the creation and application of machine-learned predictive segments in just a few clicks. Predictive
Read More
Vascular Therapies announces clinical results from its Phase 3 randomized multicenter clinical trial
CRESSKILL, N.J. — Vascular Therapies, a privately held biotechnology company is developing Sirogen, a proprietary sirolimus formulation for intraoperative local drug delivery to reduce surgical stenosis in blood vessels. Today the company announced clinical results from its Phase 3 clinical trial in which Sirogen showed encouraging AV fistula outcomes in
Read More
Zeotap builds momentum as marketing industry shifts away from cookies
April 14th, 2021 – Zeotap, the Customer Intelligence Platform (CIP), has reported 126% ARR growth in 2020 among its latest milestones in growth. Building momentum from its $60.5 million Series C fundraising round last year, the company is capitalizing on the marketing industry’s move to better engage first-party data in
Read More
Achronix now shipping industry’s highest performance Speedster7t FPGA devices
Santa Clara, Calif., April 8, 2021 – Achronix Semiconductor Corporation, a leader in high-performance FPGAs and embedded FPGA (eFPGA) IP, today announced that it has begun shipping its 7nm Speedster®7t AC7t1500 FPGAs to customers ahead of schedule. The Speedster7t family is purpose-built for high bandwidth workloads in a broad range
Read More
ABL Space raises $170m growth equity round led by T. Rowe Price funds
EL SEGUNDO, Calif., March 25, 2021 /PRNewswire/ -- ABL Space Systems has closed a Series B investment round of $170 million at a valuation of $1.3 billion. The round was led by funds and accounts advised by T. Rowe Price Associates, Inc. Participation in the round included existing ABL investors
Read More
Ventyx Biosciences doses first subject in a Phase 1 Trial of VTX-958, a selective allosteric TYK2 Inhibitor for Autoimmune Diseases
Study to evaluate pharmacokinetics, safety and tolerability of VTX-958 as well as effects on biomarkers of TYK2-driven inflammatory signaling ENCINITAS, March 16, 2021 /PRNewswire/ — Ventyx Biosciences, Inc. a clinical-stage biotechnology company developing oral, small molecule therapeutics for autoimmune disease, today announced the dosing of the first subject in a
Read More
New Science Ventures Portfolio Company Ventyx Biosciences Raises $114 Million
New York (NY, US), London (UK), March 9th, 2021 – New Science Ventures LLC (“NSV”), a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value, announces that its portfolio company Ventyx Biosciences raised $114 million from blue-chip investors to advance a diverse pipeline
Read More
iCAD – New research supporting ProFound AI presented at European congress of radiology online meeting
iCAD showcased expanded ProFound AI platform, including ProFound AI Risk, the world’s first clinical decision support tool that provides a highly accurate short-term risk estimation specific to each woman. NASHUA, N.H. – March 8, 2021 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and
Read More
Isorg obtains FBI certification for security market’s first organic photodiode-based module for fingerprint scanners
US approval of FAP 10 module, first in a new category of optical sensors, is approbation that global biometrics market is ready for organic electronics in security applications. Limoges, France, March 8, 2021 – Isorg, a pioneer in organic photodetectors (OPDs) and large-area image sensors, today announces its Fingerprint Acquisition
Read More
iCAD announces closing of $25.0 million public offering of common stock and full exercise of underwriters’ option to purchase additional shares
NASHUA, N.H., March 08, 2021 -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the closing on March 5, 2021 of its previously announced underwritten public offering of 1,393,738 shares of common stock at a public offering price
Read More
ProterixBio announces commercial availability of a quantitative COVID-19 serology test validated for dried blood spots from a finger stick
Billerica, MA, February 11, 2020: ProterixBio, Inc. announced today commercial availability of a quantitative COVID-19 serology assay that has been validated for dried blood spots (DBS) from a finger stick. This is an update to the previously released SARS-CoV-2 (RBD) IgG Antibody test and is being offered as a testing
Read More
DataCore Software acquires Caringo, Inc.
DataCore Software, the authority on software-defined storage, today announced that it has acquired Caringo, Inc. The combined entity will enable DataCore to offer complete, best-of-breed software-defined storage solutions for block, file, and object—from a single vendor. The acquisition will also add talent and expertise to the DataCore team, as well
Read More